186 related articles for article (PubMed ID: 7279699)
1. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
2. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
3. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
Ahlemann LM; Staab HJ; Anderer FA
Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
Paulick R; Caffier H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
Ahlemann LM; Staab HJ; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
[TBL] [Abstract][Full Text] [Related]
7. Human tissue polypeptide antigen in breast cancer.
Nemoto T; Constantine R; Chu TM
J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
[TBL] [Abstract][Full Text] [Related]
8. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
Paulick R; Caffier H
Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
[TBL] [Abstract][Full Text] [Related]
12. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
13. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
Gropp C; Lehmann FG; Havemann K
Dtsch Med Wochenschr; 1977 Jul; 102(30):1079-82. PubMed ID: 891388
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic-like substance in breast fluid discharge in benign and malignant breast disease and in milk of lactating women.
Kahana L; Bartal AH; Yechieli H; Guttman I; Sheinfeld M
Isr J Med Sci; 1981 Nov; 17(11):1035-40. PubMed ID: 7319791
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
16. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma.
al-Jarallah MA; Behbehani AE; el-Nass SA; Temim L; Ebraheem AK; Ali MA; Szymendera JJ
Eur J Surg Oncol; 1993 Feb; 19(1):74-9. PubMed ID: 8436243
[TBL] [Abstract][Full Text] [Related]
17. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases.
Kumar Y; Pinedo IR; Tapuria N; Zabron A; Davidson BR
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):1006-11. PubMed ID: 18787469
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.
Blijlevens NM; Oosterhuis WP; Oosten HR; Mulder NH
Anticancer Res; 1995; 15(6B):2711-6. PubMed ID: 8669851
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers.
Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S
Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
